Maintenance Notice (10:30 PM January 4 - 8:00 AM January 5, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 30652-11-0 | Product Number: H0944
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
×
![]()
×
Purity: >98.0%(GC)(T)
Synonyms:
- Deferiprone
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
₩87,000
|
15 | ≥100 | Contact Us | |
| 25G |
₩275,700
|
34 | 2 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | H0944 |
| Purity / Analysis Method | >98.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__7H__9NO__2 = 139.15 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 30652-11-0 |
| Reaxys Registry Number | 1447108 |
| PubChem Substance ID | 87571300 |
| SDBS (AIST Spectral DB) | 16851 |
| Merck Index (14) | 2859 |
| MDL Number | MFCD00134497 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Solubility in Acetic acid | almost transparency |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 260 °C(dec.) |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | UU7785940 |
Transport Information:
| H.S.code* | 2933.39-000 |
Application
Mitophagy research
References
- Loss of iron triggers PINK1/Parkin-independent mitophagy
- PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65
Application
Deferiprone: A Potent Chelating Agent with an Affinity for Ferric Ion [Fe (III)]
Deferiprone is a potent chelating agent with an affinity for ferric ion [Fe (III)]. Reportedly, deferiprone binds with ferric ions to form neutral 3:1 (deferiprone:iron) complexes that are stable over a wide range of pH values. And then, deferiprone has a lower binding affinity for other metals such as copper, aluminum and zinc than for iron. Deferiprone, an iron chelator that may cross the blood-brain barrier, is used therapeutically in conditions of transfusional iron overload and Friedreich's ataxia (FRDA) for the excretion of iron. (The product is for research purpose only.)
References
- Role of deferiprone in chelation therapy for transfusional iron overload (a review)
- Oral chelators Deferasirox and Deferiprone for transfusional iron overload in thalassemia major: new data, new questions
- Deferiprone for the treatment of Friedreich's ataxia
- Chromatography of 3-hydroxypyridin-4-ones: novel orally active iron chelators
- Development of a fast LC-MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.